Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 29 April and 1 May 2015, thirty-eight surgical trainees from the Oxford and Severn Deaneries attended the first Bristol Oxford Surgical Trials Course (BOSTiC) - a joint initiative between the Oxford Surgical Intervention Trials Unit (SITU) at the Nuffield Department of Surgical Sciences and the Bristol Surgical Trials Centre (BSTC).

Load More

Similar stories

Analysis identifies 50 new genomic regions associated with kidney cancer risk

In a new analysis of genetic susceptibility to kidney cancer, an international team of researchers, including Professor Mark Sullivan from Oxford University's Nuffield Department of Surgical Sciences, has identified 50 new areas across the genome that are associated with the risk of developing kidney cancer.